88 related articles for article (PubMed ID: 8508471)
41. Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype.
Ohmichi N; Iwai N; Uchida Y; Shichiri G; Nakamura Y; Kinoshita M
Am J Hypertens; 1997 Aug; 10(8):951-5. PubMed ID: 9270093
[TBL] [Abstract][Full Text] [Related]
42. Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome.
Fogari R; Zoppi A; Mugellini A; Maffioli P; Lazzari P; Derosa G
Hypertens Res; 2011 Dec; 34(12):1321-6. PubMed ID: 21814211
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Lu S; Jiang K; Qin F; Lu X; Li F
J Pharm Biomed Anal; 2009 Jan; 49(1):163-7. PubMed ID: 19046843
[TBL] [Abstract][Full Text] [Related]
44. Studies on angiotensin converting enzyme inhibitors. VI. Synthesis and angiotensin converting enzyme inhibitory activities of the dicarboxylic acid derivative of imidapril and its diastereoisomers.
Kubota H; Nunami K; Hayashi K; Hashimoto Y; Ogiku N; Matsuoka Y; Ishida R
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1619-22. PubMed ID: 1394683
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
[TBL] [Abstract][Full Text] [Related]
46. Hydrophilic interaction liquid chromatography/positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma.
Georgakakou S; Kazanis M; Panderi I
Anal Bioanal Chem; 2010 Jul; 397(6):2161-70. PubMed ID: 20195579
[TBL] [Abstract][Full Text] [Related]
47. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
[TBL] [Abstract][Full Text] [Related]
48. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
Abdallah OM; Abdel-Megied AM; Gouda AS
Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
[TBL] [Abstract][Full Text] [Related]
49. Determination of CGS 16617 and stable isotope-labeled CGS 16617, an angiotensin-converting enzyme inhibitor, in human plasma by gas chromatography/mass spectrometry.
Gaudry D; Hayes M; Khemani L; Miotto J; Alkalay D
Biol Mass Spectrom; 1991 Jan; 20(1):26-30. PubMed ID: 1883857
[TBL] [Abstract][Full Text] [Related]
50. Rapid quantification of lisinopril in human plasma by liquid chromatography/tandem mass spectrometry.
Qin W; Zhang Z; Tian Y; Xu F; Wang N; Chen Y
Biomed Chromatogr; 2007 Apr; 21(4):415-21. PubMed ID: 17221934
[TBL] [Abstract][Full Text] [Related]
51. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
[TBL] [Abstract][Full Text] [Related]
52. Imidapril inhibits cerebral aneurysm formation in an angiotensin-converting enzyme-independent and matrix metalloproteinase-9-dependent manner.
Ishibashi R; Aoki T; Nishimura M; Miyamoto S
Neurosurgery; 2012 Mar; 70(3):722-30. PubMed ID: 21937941
[TBL] [Abstract][Full Text] [Related]
53. A high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method using solid phase extraction for the simultaneous determination of plasma concentrations of enalapril and enalaprilate in hypertensive patients treated with different pharmaceutical formulations.
Lima DM; Mundim IM; Jardim PC; Jardim TS; Diniz DG; Lima EM
Ther Drug Monit; 2009 Dec; 31(6):710-6. PubMed ID: 19701113
[TBL] [Abstract][Full Text] [Related]
54. Clinical analysis of sampatrilat, a combined renal endopeptidase and angiotensin-converting enzyme inhibitor I: assay in plasma of human volunteers by atmospheric-pressure ionisation mass-spectrometry following derivatisation with BF3-methanol.
Venn RF; Kaye B; Macrae PV; Saunders KC
J Pharm Biomed Anal; 1998 Jan; 16(5):875-81. PubMed ID: 9535199
[TBL] [Abstract][Full Text] [Related]
55. Simultaneous quantitation of enalapril and enalaprilat in human plasma by 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
Lee J; Son J; Lee M; Lee KT; Kim DH
Rapid Commun Mass Spectrom; 2003; 17(11):1157-62. PubMed ID: 12772271
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous determination of asperosaponin VI and its active metabolite hederagenin in rat plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study.
Zhu H; Ding L; Shakya S; Qi X; Hu L; Yang X; Yang Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3407-14. PubMed ID: 21963276
[TBL] [Abstract][Full Text] [Related]
57. Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography--mass spectrometry and its application to pharmacokinetic studies.
Franklin ME; Addison RS; Baker PV; Hooper WD
J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):47-54. PubMed ID: 9498669
[TBL] [Abstract][Full Text] [Related]
58. A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for moexipril, an angiotensin-converting enzyme inhibitor in human plasma.
Karra VK; Mullangi R; Pilli NR; Inamadugu JK; Ravi VB; Seshagiri Rao JV
Biomed Chromatogr; 2012 Dec; 26(12):1552-8. PubMed ID: 22419504
[TBL] [Abstract][Full Text] [Related]
59. Imidapril in heart failure.
Dolezal T
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):146-54. PubMed ID: 17094051
[TBL] [Abstract][Full Text] [Related]
60. Clearance of imidapril, an Angiotensin-converting enzyme inhibitor, during hemodialysis in hypertensive renal failure patients: comparison with quinapril and enalapril.
Tsuruoka S; Kitoh Y; Kawaguchi A; Sugimoto K; Hayasaka T; Saito T; Fujimura A
J Clin Pharmacol; 2007 Feb; 47(2):259-63. PubMed ID: 17244777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
